Healthcare Infection Control Practices Advisory Committee (HICPAC), 9477 [2016-03929]

Download as PDF 9477 Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices eliminate existing barriers to treatment so that young women have access to high quality breast cancer treatment and care. Results will also be used to improve care and services provided to young women diagnosed with breast cancer. Study findings will be disseminated through reports, presentations, and publications. OMB approval is requested for one year. Participation is voluntary and there are no costs to respondents other than their time. The total estimated annualized burden hours are 1,241. ESTIMATED TOTAL BURDEN HOURS Number of respondents Type of respondent Form name Sample 1—Breast cancer survivors recruited from state cancer registries. Sample 2—Breast cancer survivors associated with advocacy groups (ineligibles). Sample 2—Breast cancer survivors associated with advocacy groups (eligible and complete). Breast Cancer in Young Women Survey (Mail-in or web-based questionnaire). Breast Cancer in Young Women Survey (Screener only). Breast Cancer in Young Women Survey (Screener and Web-based questionnaire). Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–04013 Filed 2–24–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting for the aforementioned committee: Times and Dates: 9:00 a.m.–5:00 p.m., EDT, March 31, 2016; 9:00 a.m.–12:00 p.m., EDT, April 1, 2016. Place: Centers for Disease Control and Prevention, Global Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE., Atlanta, Georgia, 30333. Status: Open to the public, limited only by the space available. Please register for the meeting at www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion, the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health and Human Services regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. VerDate Sep<11>2014 18:07 Feb 24, 2016 Jkt 238001 Matters for Discussion: The agenda will include updates on CDC’s activities for prevention of healthcare associated infections (HAIs), updates on antimicrobial stewardship, an update on Draft Guideline for Prevention of Infections in Healthcare Personnel, chlorhexidine gluconateimpregnated dressings, and an update from the workgroup for considerations on endoscope reprocessing. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Erin Stone, M.S., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE., Mailstop A–07, Atlanta, Georgia 30333. Telephone (404) 639–4045. Email: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–03929 Filed 2–24–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting Name: ICD–10 Coordination and Maintenance (C&M) Committee meeting. Time and Date: 9:00 a.m.–5:00 p.m., EST, March 9–10, 2016. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hours) 1,200 1 22/60 25 1 2/60 2,000 1 24/60 7500 Security Boulevard, Baltimore, Maryland 21244. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at http:// www.cms.gov/live/. Security Considerations: Due to in creased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend the March 9–10, 2016 ICD–10–CM C&M meeting must submit their name and organization by March 1, 2016 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous Coordination and Maintenance meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend. Please register to attend the meeting on-line at: http://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786–4510 or Marilu.hue@ cms.hhs.gov), for questions about the registration process. Purpose: The ICD–10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10 Procedure Coding System. Matters for Discussion: Agenda items include: March 9–10, 2016. E:\FR\FM\25FEN1.SGM 25FEN1

Agencies

[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Page 9477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03929]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting for the aforementioned 
committee:

    Times and Dates: 9:00 a.m.-5:00 p.m., EDT, March 31, 2016; 9:00 
a.m.-12:00 p.m., EDT, April 1, 2016.
    Place: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road 
NE., Atlanta, Georgia, 30333.
    Status: Open to the public, limited only by the space available. 
Please register for the meeting at www.cdc.gov/hicpac.
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion, 
the Director, National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID), the Director, CDC, the Secretary, Health and 
Human Services regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related 
events in settings where healthcare is provided; and (3) periodic 
updating of CDC guidelines and other policy statements regarding 
prevention of healthcare-associated infections and healthcare-
related conditions.
    Matters for Discussion: The agenda will include updates on CDC's 
activities for prevention of healthcare associated infections 
(HAIs), updates on antimicrobial stewardship, an update on Draft 
Guideline for Prevention of Infections in Healthcare Personnel, 
chlorhexidine gluconate-impregnated dressings, and an update from 
the workgroup for considerations on endoscope reprocessing.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Erin Stone, M.S., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton 
Road NE., Mailstop A-07, Atlanta, Georgia 30333. Telephone (404) 
639-4045. Email: hicpac@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-03929 Filed 2-24-16; 8:45 am]
 BILLING CODE 4163-18-P